FDA Updates for the Week of July 10, 2023
FDA Updates for the Week of July 10, 2023 unknown
FDA Approves First Nonprescription Oral Contraceptive.
The FDA has approved
FDA Updates for Week of July 3, 2023
FDA Updates for Week of July 3, 2023 unknown
CMS Expands Leqembi Coverage After FDA’s Full Approval
The Centers
FDA Updates for Week of June 26, 2023
FDA Updates for Week of June 26, 2023 unknown
FDA Approves $2.9 Million Gene Therapy for Hemophilia A
The
FDA Updates for the Week of June 19, 2023
FDA Updates for the Week of June 19, 2023 unknown
First Gene Therapy for Duchenne Priced at $3.2 Million.
New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy
New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy unknown
* This
South Korean AI software for sepsis detection gets US FDA nod and more briefs
Roundup: South Korean AI software for sepsis detection gets US FDA nod and more briefs unknown
SpassMed scores US FDA
Owlet receives FDA clearance for its pulse oximetry sock for infants
Owlet receives FDA clearance for its pulse oximetry sock for infants unknown
Owlet, a tech company focusing on smart baby
Exclusive: Huma receives US FDA Class II clearance for SaMD ...
Exclusive: Huma receives US FDA Class II clearance for SaMD ... unknown
Huma Therapeutics has received US Food and Drug Administration
US FDA grants 510(k) Class II regulatory clearance to Huma Therapeutics' configurable SaMD disease management platform
US FDA grants 510(k) Class II regulatory clearance to Huma Therapeutics' configurable SaMD disease management platform unknown
Huma
Virtual And Digital Health Digest - Healthcare - Worldwide
Virtual And Digital Health Digest - Healthcare - Worldwide unknown
To print this article, all you need is to be